Alnylam Pharmaceuticals, Inc. (ALNY): Stock Offering News

ALNY – Prices offering of 5.6 mln shares of its common stock at $125.00 per share.


Key Facts Surrounding This News Item


  • ALNY had a POWR Rating of B (Buy) coming into today.
  • ALNY was -1.29% below its 10-Day Moving Average coming into today.
  • ALNY was 4.04% above its 20-Day Moving Average coming into today.
  • ALNY was 15.11% above its 50-Day Moving Average coming into today.
  • ALNY was 33.24% above its 100-Day Moving Average coming into today.
  • ALNY was 68.35% above its 200-Day Moving Average coming into today.
  • ALNY had returned +244.85% year-to-date leading up to today’s news, versus a +17.22% return from the benchmark S&P 500 during the same period.

More Info About Alnylam Pharmaceuticals, Inc. (ALNY)


Alnylam Pharmaceuticals is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi. The company was founded in 2002 and is based in Cambridge, Massachusetts. View our full ALNY ticker page with ratings, news, and more.

ALNY at a Glance

ALNY Current POWR Rating™
Overall POWR Rating™
ALNY Current Price $127.51 0.89%
More ALNY Ratings, Data, and News

ALNY Price Reaction

The day of this event (Nov. 14, 2017)
ALNY Closing Price$130.32 0.94%
ALNY Volume3,301,900
181.80% from avg
Leading up to this event
ALNY 1-mo returnN/A%
After this event
ALNY 1-day return2.51%
ALNY 3-day return1.25%

ALNY Price Chart



More Alnylam Pharmaceuticals, Inc. (ALNY) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All ALNY News
Page generated in 0.9072 seconds.